29 Jul 2020
Hetero Launches Generic COVID-19 Treatment Drug Favipiravir in India under brand name FAVIVIR
Gastro Division

After Covifor Injection, Hetero developed the second drug 'Favipiravir' for treatment of mild to moderate Coronavirus symptoms following the approvals from the Drug Controller General of India (DCGI) to manufacture and market the generic drug under the brand name Favivir. It is an oral antiviral medicine that has exhibited positive clinical results.